| #164 |
Md Nasim Hyder |
MIT |
1 |
| #164 |
Shota Nakade |
MIT |
1 |
| #164 |
James Spoonamore |
Synlogic Operating Company |
1 |
| #164 |
Serdar Kadioglu |
Fmr |
1 |
| #164 |
Sheila A. Longo |
Irobot |
1 |
| #164 |
Pei Lu |
I2 Technologies Us |
1 |
| #164 |
Nicholas LaPenn |
Izotope |
1 |
| #164 |
Gabriel Billings |
Brigham and Women's Hospital |
1 |
| #164 |
Bei Yu |
AT&T |
1 |
| #164 |
Ruth Foreman |
Whitehead Institute For Biomedical Research |
1 |
| #164 |
Maksim Makeev |
Owl Labs |
1 |
| #164 |
Paul Voss |
CNRS |
1 |
| #164 |
Donald P. Carney |
Fluidity Software |
1 |
| #164 |
Troy Jones |
Draper Laboratory |
1 |
| #164 |
Neil F. Hesek |
RTX (Raytheon) |
1 |
| #164 |
Oliver Jia-Richards |
MIT |
1 |
| #164 |
Amit Hochman |
Ansys |
1 |
| #164 |
Cinzia Metallo |
Trustees Of Tufts College |
1 |
| #164 |
Emily Pearce |
Sharkninja Operating |
1 |
| #164 |
Vanita D. Sood |
Merck |
1 |
| #164 |
John R. BUTLER |
Amgen |
1 |
| #164 |
Thomas Nadovich |
Silverside Detectors |
1 |
| #164 |
Benjamin Beckvold |
Monotony.Ai |
1 |
| #164 |
David Harvie Porter |
L3 Open Water Power |
1 |
| #164 |
Alyssa Pierson |
MIT |
1 |
| #164 |
Peter Mason |
Regeneron Pharmaceuticals |
1 |
| #164 |
Debabrata Banerjee |
Akamai Technologies |
1 |
| #164 |
Shannon Terry |
Scpharmaceuticals |
1 |
| #164 |
James Gifford |
Takeda Vaccines |
1 |
| #164 |
Liyi Xu |
MIT |
1 |
| #164 |
Vincent Jacques |
Biomarin Pharmaceutical |
1 |
| #164 |
Matthew Li |
MIT |
1 |
| #164 |
Kichul Cha |
Inbody Co. |
1 |
| #164 |
Trevor Ruggiero |
S.D. Sight Diagnostics |
1 |
| #164 |
Joseph Lobacki |
Finch Therapeutics Holdings |
1 |
| #164 |
Daniel Mulhern |
Bluefin Biomedicine |
1 |
| #164 |
Daniel Dahlberg |
Bitsight Technologies |
1 |